赛托生物
(300583)
| 流通市值：24.23亿 | | | 总市值：24.76亿 |
| 流通股本：1.86亿 | | | 总股本：1.90亿 |
| 报告期 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 284,575,520.5 | 410,642,497.52 | 249,546,369.14 | 188,398,286.35 |
| 应收票据及应收账款 | 196,931,778.08 | 247,850,788.82 | 244,889,134.78 | 196,565,259.17 |
| 应收账款 | 196,931,778.08 | 247,850,788.82 | 244,889,134.78 | 196,565,259.17 |
| 应收款项融资 | 59,680,889.32 | 143,273,703.85 | 57,614,996.49 | 88,657,331.61 |
| 预付款项 | 22,732,644.76 | 7,758,859.21 | 39,910,047.73 | 27,483,395.24 |
| 其他应收款合计 | 14,850,655.4 | 11,332,382.77 | 12,372,200.62 | 11,545,221.06 |
| 存货 | 846,749,036.69 | 776,035,531 | 635,759,362.23 | 608,261,782.36 |
| 其他流动资产 | 29,956,520.75 | 28,952,526.11 | 19,374,332.88 | 19,030,323.36 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,455,477,045.5 | 1,625,846,289.28 | 1,259,466,443.87 | 1,139,941,599.15 |
| 非流动资产: | | | | |
| 长期股权投资 | 64,834,353.59 | 68,262,515.27 | 64,421,451.89 | 63,200,365.96 |
| 其他权益工具投资 | - | - | 3,000,000 | - |
| 固定资产 | 1,258,086,258.94 | 1,278,568,680.82 | 1,273,979,255.13 | 1,309,106,728.9 |
| 在建工程 | 305,567,500.17 | 302,019,111.64 | 319,689,501.88 | 292,424,127.61 |
| 使用权资产 | 9,628,920.68 | 10,683,173.32 | 2,960,695.61 | 4,039,390.26 |
| 无形资产 | 198,892,823.81 | 198,552,111.67 | 169,865,758.15 | 172,898,571.65 |
| 长期待摊费用 | 1,346,942.21 | 1,471,621.07 | - | - |
| 递延所得税资产 | 11,751,326.6 | 13,403,251.36 | 8,810,429.66 | 8,952,896.39 |
| 其他非流动资产 | 4,712,792.45 | 7,300,209.4 | 5,114,700 | 5,114,700 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,854,820,918.45 | 1,880,260,674.55 | 1,847,841,792.32 | 1,855,736,780.77 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,310,297,963.95 | 3,506,106,963.83 | 3,107,308,236.19 | 2,995,678,379.92 |
| 流动负债: | | | | |
| 短期借款 | 611,176,840 | 701,218,946.47 | 568,696,686.68 | 539,748,236.09 |
| 应付票据及应付账款 | 307,661,689.63 | 418,272,004.43 | 477,977,251.56 | 402,691,382.77 |
| 其中：应付票据 | 92,853,592.45 | 154,485,344.85 | 208,515,856.28 | 145,714,334.84 |
| 应付账款 | 214,808,097.18 | 263,786,659.58 | 269,461,395.28 | 256,977,047.93 |
| 合同负债 | 10,074,618.82 | 15,711,758.84 | 9,768,622.53 | 10,465,445.66 |
| 应付职工薪酬 | 21,657,573.71 | 23,673,223.51 | 17,711,311.82 | 22,191,998.93 |
| 应交税费 | 11,558,801.37 | 14,800,993.44 | 15,912,691.67 | 11,930,709.54 |
| 其他应付款合计 | 41,258,947.09 | 52,101,435.37 | 57,612,556.76 | 60,594,549.13 |
| 一年内到期的非流动负债 | 48,506,804.84 | 39,082,523.24 | 36,051,352.45 | 36,495,337.13 |
| 其他流动负债 | 633,372.01 | 857,101.09 | 574,520.82 | 340,881.2 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,052,528,647.47 | 1,265,717,986.39 | 1,184,304,994.29 | 1,084,458,540.45 |
| 非流动负债: | | | | |
| 长期借款 | 136,739,365.17 | 118,881,595.19 | 120,298,240.42 | 122,700,502.22 |
| 租赁负债 | 7,251,984.24 | 7,655,340.21 | 382,069.73 | 1,007,628.6 |
| 递延收益 | 25,353,030.5 | 26,158,560.1 | 14,514,089.7 | 15,163,994.3 |
| 递延所得税负债 | 3,093,608.25 | 3,216,379.73 | 912,287.56 | 1,469,679.13 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 172,437,988.16 | 155,911,875.23 | 136,106,687.41 | 140,341,804.25 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 1,224,966,635.63 | 1,421,629,861.62 | 1,320,411,681.7 | 1,224,800,344.7 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 189,702,126 | 118,563,829 | 106,922,067 | 106,922,067 |
| 资本公积 | 1,276,889,758.87 | 1,348,095,167.47 | 1,107,814,521.32 | 1,107,814,521.32 |
| 其他综合收益 | -474,364.53 | -375,865.67 | 1,250,704.28 | 2,630,616.19 |
| 盈余公积 | 87,727,115.4 | 87,727,115.4 | 87,727,115.4 | 87,727,115.4 |
| 未分配利润 | 474,421,600.57 | 473,231,707.63 | 430,416,848.48 | 415,042,583.03 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 2,028,266,236.31 | 2,027,241,953.83 | 1,734,131,256.48 | 1,720,136,902.94 |
| 少数股东权益 | 57,065,092.01 | 57,235,148.38 | 52,765,298.01 | 50,741,132.28 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 2,085,331,328.32 | 2,084,477,102.21 | 1,786,896,554.49 | 1,770,878,035.22 |
| 负债和股东权益合计 | 3,310,297,963.95 | 3,506,106,963.83 | 3,107,308,236.19 | 2,995,678,379.92 |
| 公告日期 | 2023-10-21 | 2023-07-31 | 2023-04-25 | 2023-04-25 |
| 审计意见(境内) | | 标准无保留意见 | | 标准无保留意见 |